Department of Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Clinical & Experimental Medicine, University of Surrey, Guildford, UK.
BMJ Open. 2023 Aug 24;13(8):e068387. doi: 10.1136/bmjopen-2022-068387.
Hypokalaemia and hyperkalaemia ('dyskalaemia') are commonly seen in patients requiring emergency hospital admission. The adverse effect of dyskalaemia on mortality is well described but there are few data for the effect on hospital length of stay. We sought to determine the association of serum potassium concentration with in-hospital length of stay.
Systematic review and meta-analysis.
A structured search of MEDLINE, PubMed and SCOPUS databases to 19 March 2021.
Observational cohort studies defining exposure of interest as serum potassium levels (at admission or within the first 72 hours) and with outcome of interest as length of hospital stay. Studies had to provide estimates of length of stay as a comparison between normokalaemia and defined ranges of hyperkalaemia or hypokalaemia.
We identified 39 articles published to March 2021 that met the inclusion and exclusion criteria. Study selection, data extraction and quality assessment were carried out by two reviewers working independently and in duplicate, to assessed eligibility and risk of bias, and extract data from eligible studies. Random effects models were used to pool estimates across the included studies. Meta-analyses were performed using Cochrane-RevMan.
Five studies were included in the meta-analysis. Compared with the reference group (3.5-5.0 mmol/L), the pooled raw differences of medians were 4.45 (95% CI 2.71 to 6.91), 1.99 (95% CI 0.03 to 3.94), 0.98 (95% CI 0.91 to 1.05), 1.51 (95% CI 1.03 to 2.0), 1 (95% CI 0.75 to 1.25) and 2.76 (95% CI 1.24 to 4.29) for patients with potassium levels of <2.5, 2.5 to <3.0, 3.0 to <3.5, <5 to 5.5, <5.5 to 6 and >6.0 mmol/L, respectively.
Hospital length of stay follows a U-shaped distribution, with duration of admission being twofold greater at the extremes of the potassium range.
低钾血症和高钾血症(“电解质紊乱”)在需要紧急住院的患者中很常见。电解质紊乱对死亡率的不良影响已有充分描述,但关于其对住院时间长短影响的数据较少。我们旨在确定血清钾浓度与住院时间长短的关系。
系统综述和荟萃分析。
2021 年 3 月 19 日之前,对 MEDLINE、PubMed 和 SCOPUS 数据库进行了结构化检索。
观察性队列研究,将血清钾水平(入院时或入院后 72 小时内)作为暴露因素,将住院时间长短作为结局指标。研究必须提供住院时间长短的估计值,作为与正常血钾和定义范围的高钾血症或低钾血症的比较。
我们确定了 39 篇符合纳入和排除标准的文章。两位评审员独立且重复地进行研究选择、数据提取和质量评估,以评估合格性和偏倚风险,并从合格研究中提取数据。使用随机效应模型汇总纳入研究的估计值。使用 Cochrane-RevMan 进行荟萃分析。
共有 5 项研究纳入荟萃分析。与参考组(3.5-5.0mmol/L)相比,汇总中位数的原始差异分别为 4.45(95%CI 2.71 至 6.91)、1.99(95%CI 0.03 至 3.94)、0.98(95%CI 0.91 至 1.05)、1.51(95%CI 1.03 至 2.0)、1(95%CI 0.75 至 1.25)和 2.76(95%CI 1.24 至 4.29),分别代表血钾水平<2.5mmol/L、2.5-<3.0mmol/L、3.0-<3.5mmol/L、<5-5.5mmol/L、<5.5-6mmol/L 和>6.0mmol/L 的患者。
住院时间长短呈 U 形分布,钾范围两端的住院时间延长一倍。